CRT 2026

TAVR | Treatment of Asymptomatic Severe Aortic Stenosis - Do We Have Enough Data to Change the Guidelines? What is the Minimalistic Approach?

Speaker(s)

• 

  Jeffrey A. Southard, MD, FACC, FSCAI

  Professor of Medicine Director -TAVR Program Medical Director- Cath Lab
  UC Davis Medical Center
  West Sacramento, California, United States

  Disclosure(s): Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips; Abbott: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)